斑秃前沿研究：Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study.
Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study.
JAK inhibitors demonstrated sustained efficacy in severe AA. Multimodal assessment combining SALT, trichoscopy, and RCM enables precise biological response monitoring. RCM uniquely detects subclinical perifollicular inflammation persisting despite clinical improvement, potentially predicting relapse risk after treatment discontinuation.
临床对照试验、真实世界队列或系统评价与Meta分析
评估JAK-STAT通路靶向方案在临床干预中的疗效反应、安全性与耐受性
- 文献原题：Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study.
- 发表期刊：Dermatology and Therapy（IF: 3.9 | 3区 | Q2）
- 🔗 DOI 直达：10.1007/s13555-026-01928-2 | 🏛️ PubMed PMID：
42825997 - 研究方法与样本量：临床对照试验、真实世界队列或系统评价与Meta分析
- 核心机制与分子靶点：评估JAK-STAT通路靶向方案在临床干预中的疗效反应、安全性与耐受性
JAK inhibitors demonstrated sustained efficacy in severe AA. Multimodal assessment combining SALT, trichoscopy, and RCM enables precise biological response monitoring. RCM uniquely detects subclinical perifollicular inflammation persisting despite clinical improvement, potentially predicting relapse risk after treatment discontinuation.
📊 核心临床 / 实验数据
- Mean Severity of Alopecia Tool (SALT) decreased from 85% at baseline to 17% at week 60. Upadacitinib treated patients showed faster early response (32.6%% SALT reduction at week 12
- 队列随访与客观结局评价进一步证实了规范化方案的临床价值
🩺 专家临床启示与转化视角
该临床研究为相关疾病的规范化临床诊疗路径、用药决策与获益风险权衡提供了最新高级别循证医学支持。